Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
SKRR to Commence Uranium Drill Program to Test Conductors at Clearwater West (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News OptiNose Inc OPTN

Healthcare
OptiNose, Inc. is a pharmaceutical company focused on patients treated by ear, nose and throat (ENT) and allergy specialists. The Company's product, XHANCE (fluticasone propionate) nasal spray, 93 microgram (mcg), is a therapeutic utilizing its Exhalation Delivery System (EDS) that delivers a topically-acting corticosteroid for the treatment of chronic rhinosinusitis with nasal polyps and... see more

Recent & Breaking News (NDAQ:OPTN)

Investor Expectations to Drive Momentum within eBay, Pulse Biosciences, Evolus, Weibo, OptiNose, and The Descartes Systems Group — Discovering Underlying Factors of Influence

GlobeNewswire December 11, 2018

Optinose Announces Update to License Agreement with Avanir Pharmaceuticals for ONZETRA XSAIL  

GlobeNewswire December 11, 2018

Optinose Announces First Patient Enrolled in Clinical Trial of XHANCE for Chronic Sinusitis

GlobeNewswire December 10, 2018

Optinose to Present at the BMO Capital Markets Prescriptions for Success Healthcare Conference

GlobeNewswire December 5, 2018

Optinose Reports Third Quarter 2018 Financial Results and Recent Operational Highlights

GlobeNewswire November 13, 2018

Optinose to Report Third Quarter 2018 Financial Results and Corporate Updates on November 13, 2018

GlobeNewswire October 31, 2018

Detailed Research: Economic Perspectives on Caseys General Stores, Evolus, OptiNose, Xunlei, Molina Healthcare, and Frontline — What Drives Growth in Today's Competitive Landscape

GlobeNewswire October 22, 2018

Optinose to Highlight Data at Two Upcoming Scientific Meetings

GlobeNewswire October 3, 2018

Optinose to Present at the 2018 Cantor Global Healthcare Conference

GlobeNewswire September 24, 2018

INVESTOR ALERT: Investigation of OptiNose Announced by Holzer & Holzer

Business Wire August 14, 2018

Optinose Reports Second Quarter 2018 Financial Results and Recent Operational Highlights

GlobeNewswire August 14, 2018

Optinose to Report Second Quarter 2018 Financial Results and Corporate Updates on August 14, 2018

GlobeNewswire August 7, 2018

Optinose Named a 2018 Best Place to Work by Philadelphia Business Journal

GlobeNewswire July 2, 2018

Optinose Announces Publication of Pivotal Efficacy and Long-Term Safety Data for XHANCE in Peer Reviewed Journals

GlobeNewswire June 21, 2018

Optinose CEO Peter Miller and President and COO Ramy Mahmoud Named EY Life Sciences Entrepreneur Of The Year 2018 in Greater

GlobeNewswire June 15, 2018

Optinose Announces Closing of Public Offering and Exercise in Full of the Underwriters' Option to Purchase Additional Common Shares

GlobeNewswire June 11, 2018

Optinose Announces Pricing of Public Offering of Common Stock

GlobeNewswire June 6, 2018

Optinose Announces Launch of Public Offering of Common Stock

GlobeNewswire June 4, 2018

Optinose Reports First Quarter 2018 Financial Results and Recent Operational Highlights

GlobeNewswire May 14, 2018

OptiNose, Inc. to Host Earnings Call

Accesswire May 14, 2018